FDA says volume manufacturing deadline is not a requirement after drugmakers lash out

Back in October, the FDA released a controversial draft guidance explaining to drug manufacturers how, beginning on Feb. 15, 2022, the FDA would start collecting annual manufacturing reports.

It would start with 2020 manufacturing data, including the volume or amount of each drug, and the same for active pharmaceutical ingredients.